Recent Use of Non-Vitamin K Antagonist Oral Anticoagulants and Intracranial Hemorrhage Among Patients With Acute Ischemic Stroke Treated With Alteplase

JAMA. 2022 Jun 21;327(23):2354-2355. doi: 10.1001/jama.2022.6350.
No abstract available

Publication types

  • Comment

MeSH terms

  • Administration, Oral
  • Anticoagulants* / administration & dosage
  • Atrial Fibrillation / drug therapy
  • Fibrinolytic Agents / adverse effects
  • Fibrinolytic Agents / therapeutic use
  • Humans
  • Intracranial Hemorrhages* / chemically induced
  • Ischemic Stroke* / drug therapy
  • Stroke / drug therapy
  • Tissue Plasminogen Activator* / adverse effects
  • Tissue Plasminogen Activator* / therapeutic use
  • Treatment Outcome
  • Vitamin K

Substances

  • Anticoagulants
  • Fibrinolytic Agents
  • Vitamin K
  • Tissue Plasminogen Activator